Interactive Panel Discussion & Q&A: De-risking Oncology Drug Discovery for Targeted Degradation

Time: 6:40 pm
day: De-risking Drug Development to Ensure Success Before Entering the Clinic

Details:

  • Review how assay development and reagent selection can influence go- and no-go decisions prior to advancing a TPD or RNAi candidate into the clinic
  • Discuss the challenges, strategies and best practices when it comes to confident results interpretation of efficacy and safety of drug candidates

More speakers TBC!

Speakers: